POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS
The purpose of the study. To evaluate immunogenicity of influenza vaccination in HIV-infected adults initially seronegative to influenza virus.Materials and methods. There were 175 HIV-infected persons and 50 healthy volunteers vaccinated against influenza in Republican center of AIDS (Ufa) in 2016-...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2018-04-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/700 |
| _version_ | 1797723279349252096 |
|---|---|
| author | R. G. Yapparov D. A. Lioznov E. Yu. Karnaukhova V. A. Larionov T. L. Galankin |
| author_facet | R. G. Yapparov D. A. Lioznov E. Yu. Karnaukhova V. A. Larionov T. L. Galankin |
| author_sort | R. G. Yapparov |
| collection | DOAJ |
| description | The purpose of the study. To evaluate immunogenicity of influenza vaccination in HIV-infected adults initially seronegative to influenza virus.Materials and methods. There were 175 HIV-infected persons and 50 healthy volunteers vaccinated against influenza in Republican center of AIDS (Ufa) in 2016-November. Titers of antibodies to influenza virus (A [H1N1], A [H3N2] and B) were detected in standard hemagglutination-inhibition reaction: before (day 0) and after (on 21th and 150th days) vaccination. Post-vaccination trends of antibodies to influenza virus were analyzed in 12 HIV-infected patients (7%) and 13 subjects from control group (26%) with the titer of antibodies lower than protective level (1/40) according to the criteria of immunogenicity for influenza vaccines for all subtypes of its antigens.Results. The shares of initially seronegative were 2–7% for HIV-infected and 12–24% Saint-Petersburg for healthy persons. Seroconversion coefficient varied from 1,6 to 2,3; seroconversion rate varied from 0 to 25%; seroprotection rate – from 67% for А (H1N1) to 100% for А (H3N2) and В. The titer of antibodies detected on day 21 didn’t decrease up to day 150 in all vaccinated persons.The analysis of the titer in HIV-infected adults with the different levels of CD4-cells demonstrated achievement of minimal protective level (1/40) in the majority of cases, and at least fourfold increase of the titer was determined when CD4-cells level was 350 cells/μl.Conclusion. Single immunization of HIV-infected adults with standard vaccine for seasonal prevention of influenza is insufficient for creation of adequate immune response. A small sample of the study does not allow extrapolating the results of studies to large cohorts of patients with HIV infection. Further research is required to develop recommendations for vaccine prevention of influenza in patients with HIV infection. |
| first_indexed | 2024-03-12T10:00:33Z |
| format | Article |
| id | doaj.art-a4dd07182e304cd182f7ee86e16e2189 |
| institution | Directory Open Access Journal |
| issn | 2072-6732 |
| language | Russian |
| last_indexed | 2024-03-12T10:00:33Z |
| publishDate | 2018-04-01 |
| publisher | Journal Infectology |
| record_format | Article |
| series | Журнал инфектологии |
| spelling | doaj.art-a4dd07182e304cd182f7ee86e16e21892023-09-02T11:46:07ZrusJournal InfectologyЖурнал инфектологии2072-67322018-04-011019610210.22625/2072-6732-2018-10-1-96-102624POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTSR. G. Yapparov0D. A. Lioznov1E. Yu. Karnaukhova2V. A. Larionov3T. L. Galankin4Республиканский центр по профилактике и борьбе со СПИД и инфекционными заболеваниямиНаучно-исследовательский институт гриппа; Первый Санкт-Петербургский государственный медицинский университет им. академика И.П. ПавловаПервый Санкт-Петербургский государственный медицинский университет им. академика И.П. ПавловаПервый Санкт-Петербургский государственный медицинский университет им. академика И.П. ПавловаПервый Санкт-Петербургский государственный медицинский университет им. академика И.П. ПавловаThe purpose of the study. To evaluate immunogenicity of influenza vaccination in HIV-infected adults initially seronegative to influenza virus.Materials and methods. There were 175 HIV-infected persons and 50 healthy volunteers vaccinated against influenza in Republican center of AIDS (Ufa) in 2016-November. Titers of antibodies to influenza virus (A [H1N1], A [H3N2] and B) were detected in standard hemagglutination-inhibition reaction: before (day 0) and after (on 21th and 150th days) vaccination. Post-vaccination trends of antibodies to influenza virus were analyzed in 12 HIV-infected patients (7%) and 13 subjects from control group (26%) with the titer of antibodies lower than protective level (1/40) according to the criteria of immunogenicity for influenza vaccines for all subtypes of its antigens.Results. The shares of initially seronegative were 2–7% for HIV-infected and 12–24% Saint-Petersburg for healthy persons. Seroconversion coefficient varied from 1,6 to 2,3; seroconversion rate varied from 0 to 25%; seroprotection rate – from 67% for А (H1N1) to 100% for А (H3N2) and В. The titer of antibodies detected on day 21 didn’t decrease up to day 150 in all vaccinated persons.The analysis of the titer in HIV-infected adults with the different levels of CD4-cells demonstrated achievement of minimal protective level (1/40) in the majority of cases, and at least fourfold increase of the titer was determined when CD4-cells level was 350 cells/μl.Conclusion. Single immunization of HIV-infected adults with standard vaccine for seasonal prevention of influenza is insufficient for creation of adequate immune response. A small sample of the study does not allow extrapolating the results of studies to large cohorts of patients with HIV infection. Further research is required to develop recommendations for vaccine prevention of influenza in patients with HIV infection.https://journal.niidi.ru/jofin/article/view/700вакцинопрофилактикагриппвич-инфекцияиммуногенность |
| spellingShingle | R. G. Yapparov D. A. Lioznov E. Yu. Karnaukhova V. A. Larionov T. L. Galankin POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS Журнал инфектологии вакцинопрофилактика грипп вич-инфекция иммуногенность |
| title | POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS |
| title_full | POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS |
| title_fullStr | POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS |
| title_full_unstemmed | POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS |
| title_short | POST-VACCINATION IMMUNE RESPONCE IN SERONEGATIVE TO INFLUENZA VIRUS HIV-INFECTED PATIENTS |
| title_sort | post vaccination immune responce in seronegative to influenza virus hiv infected patients |
| topic | вакцинопрофилактика грипп вич-инфекция иммуногенность |
| url | https://journal.niidi.ru/jofin/article/view/700 |
| work_keys_str_mv | AT rgyapparov postvaccinationimmuneresponceinseronegativetoinfluenzavirushivinfectedpatients AT dalioznov postvaccinationimmuneresponceinseronegativetoinfluenzavirushivinfectedpatients AT eyukarnaukhova postvaccinationimmuneresponceinseronegativetoinfluenzavirushivinfectedpatients AT valarionov postvaccinationimmuneresponceinseronegativetoinfluenzavirushivinfectedpatients AT tlgalankin postvaccinationimmuneresponceinseronegativetoinfluenzavirushivinfectedpatients |